Zentek grants options to acquire 600,000 shares

2023-04-14 20:44 ET - News Release

Mr. Mitch Swergold reports

ZENTEK ANNOUNCES GRANT OF STOCK OPTIONS

Zentek Ltd. has granted 600,000 options to directors, officers and employees of the company exercisable at a price of $2.12 per common share for a period of three to five years from the date of the grant. The options will vest one-third on the date of grant, one-third after six months of the date of grant and one-third after 12 months of the date of grant for directors and c-suite members. All other options will vest one-third on the date of grant, one-third after one year of the date of grant and one-third after two years of the date of grant. These option grants are a component of the annual compensation review process.

About Zentek Ltd.

Zentek is an IP (intellectual property) development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the health care industry and beyond.

Zentek's patented ZenGuard coating is shown to have 99-per-cent anti-microbial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC (heating, ventilation and air conditioning) systems. Zentek's ZenGuard production facility is located in Guelph, Ont.

We seek Safe Harbor.